EPISODE · Nov 8, 2024 · 56 MIN
What Clinicians Want to Know About the Current and Future Role of EZH1/2 Inhibitors in the Care of Patients with Lymphoma
from Oncology Today with Dr Neil Love
Dr Gilles Salles from the Memorial Sloan Kettering Cancer Center in New York, New York, reviews current and novel EZH1/2 inhibitor-based treatment strategies for follicular lymphoma, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here.
Embed this episode
Ready to play
What Clinicians Want to Know About the Current and Future Role of EZH1/2 Inhibitors in the Care of Patients with Lymphoma
0:00
56:15
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of Oncology Today with Dr Neil Love?
This episode is 56 minutes long.
When was this Oncology Today with Dr Neil Love episode published?
This episode was published on November 8, 2024.
Can I download this Oncology Today with Dr Neil Love episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!